Lasa Supergenerics Ltd.

LASA

Market Cap
₹120 Cr.
P/E
0.00

Lasa Supergenerics Ltd.

Price
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max
locked
FAQs on Lasa Supergenerics Ltd. Shareprice

Lasa Supergenerics has given lower returns compared to its competitors.
Lasa Supergenerics has grown at ~-7.32% over the last 6yrs while peers have grown at a median rate of 10.34%

Lasa Supergenerics is expensive when considering the EV/EBIDTA, however latest PE is < 3 yr avg PE.
Latest PE of Lasa Supergenerics is 0.0, while 3 year average PE is 8.56.
Also latest EV/EBITDA of Lasa Supergenerics is 64.9 while 3yr average is 21.1.

GROWTH TABLE
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
BALANCE SHEET
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
Balance Sheet Snapshot
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
*Data is as of latest FY end
Profit & Loss
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
CASH FLOW
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
Ratios
= Dominant Factor
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
Quarterly Results
  • Lasa Supergenerics Ltd.
  • Gufic Biosciences
  • Bal Pharma
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
timeline Timeline
watchlist Watchlist
portfolio Portfolio
alerts Alerts
filter Research
filter Filter
markets Market
raw materials Raw Material
FAQs on Lasa Supergenerics Ltd. Financials

Balance sheet of Lasa Supergenerics is moderately strong, But short term working capital might become an issue for this company.

Yes, The debt of Lasa Supergenerics is increasing.
Latest debt of Lasa Supergenerics is ₹20.58 Crs as of Mar-24.
This is greater than Mar-23 when it was ₹18.42 Crs.

The profit is oscillating.
The profit of Lasa Supergenerics is -₹21.73 Crs for TTM, -₹38.62 Crs for Mar 2023 and -₹5.33 Crs for Mar 2022.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lasa Supergenerics latest dividend payout ratio is 4.46% and 3yr average dividend payout ratio is 4.46%

Companies resources are majorly tied in miscellaneous assets

Data feed provided by Accord Fintech